Cannabinoid CB2 receptor |
0.4686 |
(CHEMBL253) |
Cannabinoid CB1 receptor |
0.4431 |
(CHEMBL218) |
Cytochrome P450 2C9 |
0.3556 |
(CHEMBL 3397) |
Topoisomerase II-α, |
0.3056 |
(CHEMBL1806) |
Estrogen receptor-β |
0.1988 |
(CHEMBL242) |
Mediated Interaction |
|
|
Glycine receptor subunit α-1 |
0.5569 |
(CHEMBL5845) |
Cannabinoid CB2 receptor |
0.5351 |
(CHEMBL253) |
Cannabinoid CB1 receptor |
0.3306 |
(CHEMBL218) |
Serotonin 1e (5-HT1e) receptor |
0.2906 |
(CHEMBL2182) |
Nuclear receptor subfamily o group B member 1 |
0.2284 |
(CHEMBL1795094) |
CBD |
Direct Interaction |
|
|
Target Name |
Confidence |
ChEMBL ID |
Phosphatidylinoitol-4-phosphate-5-kinasetype 1γ |
0.7681 |
(CHEMBL1908383) |
Cannabinoid CB1 receptor |
0.6356 |
(CHEMBL218) |
Serine/Threonine-protein kinase 32A |
0.6151 |
(CHEMBL6150) |
Rhodopsin kinase |
0.5937 |
(CHEMBL5607) |
Cannabinoid CB2 receptor |
0.5239 |
(CHEMBL253) |
Mediated Interaction |
|
|
Cannabinoid CB2 receptor |
0.7529 |
(CHEMBL253) |
Glycine receptor subunit α-1 |
0.6822 |
(CHEMBL218) |
Tyrosine-protein kinase FYN |
0.4922 |
(CHEMBL3397) |
Cannabinoid CB1 receptor |
0.4637 |
(CHEMBL218) |
N-arachidonyl glycine receptor |
0.4088 |
(CHEMBL2384898) |
THCV |
Direction Interaction |
|
|
Target Name |
Confidence |
ChEMBL ID |
Phosphatidylinoitol-4-phosphate-5kinasetype 1γ |
0.8084 |
(CHEMBL1908383) |
Rhodopsin kinase |
0.6532 |
(CHEMBL5607) |
Serine/Threonine-protein kinase 32A |
0.6438 |
(CHEMBL6150) |
Cannabinoid CB1 receptor |
0.6241 |
(CHEMBL218) |
Tyrosine-protein kinase Srms |
0.5934 |
(CHEMBL5703) |
Mediated Interaction |
|
|
Glycine receptor subunit α-1 |
0.6769 |
(CHEMBL218) |
Cannabinoid CB2 receptor |
0.6167 |
(CHEMBL253) |
Tyrosine-protein kinase FYN |
0.4396 |
(CHEMBL3397) |
Cannabinoid CB1 receptor |
0.4253 |
(CHEMBL218) |
N-arachidonyl glycine receptor |
0.3361 |
(CHEMBL218) |